Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study. Blood Adv. 2023 Jul 25; 7(14):3506-3515.
View in:
PubMed
Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions. Blood Adv. 2023 07 25; 7(14):3749-3759.
View in:
PubMed
Marital status, frailty, and survival in older adults with blood cancer. J Geriatr Oncol. 2023 Jul 13; 101589.
View in:
PubMed
Mental health disorders and survival among older patients with diffuse large B-cell lymphoma in the USA: a population-based study. Lancet Haematol. 2023 Jul; 10(7):e530-e538.
View in:
PubMed
Clinical ethics consultation documentation in the era of open notes. BMC Med Ethics. 2023 05 03; 24(1):27.
View in:
PubMed
Benefits and Barriers of Technology for Home Function and Mobility Assessment: Perspectives of Older Patients With Blood Cancers, Caregivers, and Clinicians. JCO Clin Cancer Inform. 2023 04; 7:e2200171.
View in:
PubMed
Yard Work. J Clin Oncol. 2023 Feb 08; JCO2202707.
View in:
PubMed
Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial. Cancer. 2023 04 01; 129(7):1075-1084.
View in:
PubMed
Virtual frailty assessment for older adults with hematologic malignancies. Blood Adv. 2022 09 27; 6(18):5360-5363.
View in:
PubMed
Ethics Consultation in Oncology: The Search for Quality in Quantity. JCO Oncol Pract. 2022 09; 18(9):610-613.
View in:
PubMed
Association of Polypharmacy and Potentially Inappropriate Medications With Frailty Among Older Adults With Blood Cancers. J Natl Compr Canc Netw. 2022 08; 20(8):915-923.e5.
View in:
PubMed
A Process Framework for Ethically Deploying Artificial Intelligence in Oncology. J Clin Oncol. 2022 Dec 01; 40(34):3907-3911.
View in:
PubMed
Peripheral blood CD3+ T-cell gene expression biomarkers correlate with clinical frailty in patients with haematological malignancies. Br J Haematol. 2022 10; 199(1):100-105.
View in:
PubMed
Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for Intervention. J Clin Oncol. 2022 Nov 10; 40(32):3709-3718.
View in:
PubMed
Randomized controlled trial of geriatric consultation versus standard care in older adults with hematologic malignancies. Haematologica. 2022 05 01; 107(5):1172-1180.
View in:
PubMed
Impact of Allocation on Survival During Intermittent Chemotherapy Shortages: A Modeling Analysis. J Natl Compr Canc Netw. 2022 04; 20(4):335-341.e17.
View in:
PubMed
Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood. 2022 02 24; 139(8):1246-1250.
View in:
PubMed
Precancer and cancer-associated depression and anxiety among older adults with blood cancers in the United States. Blood Adv. 2022 02 22; 6(4):1126-1136.
View in:
PubMed
Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials. Blood Adv. 2021 11 09; 5(21):4352-4360.
View in:
PubMed
Defining Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Multiple Myeloma. J Natl Cancer Inst. 2021 08 02; 113(8):1084-1093.
View in:
PubMed
Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromes. Transfusion. 2021 10; 61(10):2830-2836.
View in:
PubMed
Prognostic value of disease risk score versus gait speed in older adults with lymphoma. Leuk Lymphoma. 2021 12; 62(12):2882-2889.
View in:
PubMed
Advances in Management for Older Adults With Hematologic Malignancies. J Clin Oncol. 2021 07 01; 39(19):2102-2114.
View in:
PubMed
Prevalence and Tolerance of Prognostic Uncertainty Among Thoracic Oncologists. Oncologist. 2021 08; 26(8):e1480-e1482.
View in:
PubMed
Model solutions for ethical allocation during cancer medicine shortages. Lancet Haematol. 2021 04; 8(4):e246-e248.
View in:
PubMed
Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant? Leukemia. 2021 Apr; 35(4):1223.
View in:
PubMed
Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review. PLoS One. 2021; 16(3):e0249087.
View in:
PubMed
Objective performance tests of cognition and physical function as part of a virtual geriatric assessment. J Geriatr Oncol. 2021 11; 12(8):1256-1258.
View in:
PubMed
US State Government Crisis Standards of Care Guidelines: Implications for Patients With Cancer. JAMA Oncol. 2021 02 01; 7(2):199-205.
View in:
PubMed
Gait speed, survival, and recommended treatment intensity in older adults with blood cancer requiring treatment. Cancer. 2021 03 15; 127(6):875-883.
View in:
PubMed
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant? Leukemia. 2021 04; 35(4):1166-1175.
View in:
PubMed
American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults. Blood Adv. 2020 08 11; 4(15):3528-3549.
View in:
PubMed
Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusions. Leuk Lymphoma. 2020 12; 61(12):2900-2904.
View in:
PubMed
Defining Undertreatment and Overtreatment in Older Adults With Cancer: A Scoping Literature Review. J Clin Oncol. 2020 08 01; 38(22):2558-2569.
View in:
PubMed
An Action Plan for Environmentally Sustainable Cancer Care. JAMA Oncol. 2020 04 01; 6(4):469-470.
View in:
PubMed
Perspectives Regarding Hospice Services and Transfusion Access: Focus Groups With Blood Cancer Patients and Bereaved Caregivers. J Pain Symptom Manage. 2020 06; 59(6):1195-1203.e4.
View in:
PubMed
Patient-hematologist discordance in perceived chance of cure in hematologic malignancies: A multicenter study. Cancer. 2020 03 15; 126(6):1306-1314.
View in:
PubMed
Goals of care discussions for patients with blood cancers: Association of person, place, and time with end-of-life care utilization. Cancer. 2020 02 01; 126(3):515-522.
View in:
PubMed
Patient-preferred outcomes measurement after post-mastectomy radiation therapy and immediate reconstruction. Breast J. 2020 02; 26(2):319-321.
View in:
PubMed
Outcomes for older adults with acute myeloid leukemia after an intensive care unit admission. Cancer. 2019 11 01; 125(21):3845-3852.
View in:
PubMed
Practical allocation system for the distribution of specialised care during cellular therapy access scarcity. J Med Ethics. 2019 08; 45(8):532-537.
View in:
PubMed
Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies. Blood. 2019 07 25; 134(4):374-382.
View in:
PubMed
The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes. Leuk Lymphoma. 2019 12; 60(13):3161-3171.
View in:
PubMed
Relationship between paid leave, financial burden, and patient-reported outcomes among employed patients who have undergone bone marrow transplantation. Qual Life Res. 2019 Jul; 28(7):1835-1847.
View in:
PubMed
Function, Survival, and Care Utilization Among Older Adults With Hematologic Malignancies. J Am Geriatr Soc. 2019 05; 67(5):889-897.
View in:
PubMed
Pentito. JAMA Oncol. 2019 04 01; 5(4):580.
View in:
PubMed
Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy. Leukemia. 2019 10; 33(10):2393-2402.
View in:
PubMed
Patients as experts: characterizing the most relevant patient-reported outcomes after hematopoietic cell transplantation. Bone Marrow Transplant. 2020 01; 55(1):242-244.
View in:
PubMed
How Do Blood Cancer Doctors Discuss Prognosis? Findings from a National Survey of Hematologic Oncologists. J Palliat Med. 2019 06; 22(6):677-684.
View in:
PubMed
The Best Medicine. JAMA Oncol. 2019 03 01; 5(3):350.
View in:
PubMed
Cognitive Impairment Among Older Patients With Hematologic Cancers-Reply. JAMA Oncol. 2018 12 01; 4(12):1784.
View in:
PubMed
What is the Role of the Arts in Medical Education and Patient Care? A Survey-based Qualitative Study. J Med Humanit. 2018 Dec; 39(4):431-445.
View in:
PubMed
Performance of the International Myeloma Working Group myeloma frailty score among patients 75 and older. J Geriatr Oncol. 2019 05; 10(3):486-489.
View in:
PubMed
Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North America. Biol Blood Marrow Transplant. 2019 03; 25(3):599-605.
View in:
PubMed
Perceptions of Oncologists About Sharing Clinic Notes with Patients. Oncologist. 2019 01; 24(1):e46-e48.
View in:
PubMed
Impact of lenalidomide use among non-transfusion dependent patients with myelodysplastic syndromes. Am J Hematol. 2018 09; 93(9):1119-1126.
View in:
PubMed
Patient-Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia. Oncologist. 2019 02; 24(2):247-254.
View in:
PubMed
Meaningful changes in end-of-life care among patients with myeloma. Haematologica. 2018 08; 103(8):1380-1389.
View in:
PubMed
Prevalence of Cognitive Impairment and Association With Survival Among Older Patients With Hematologic Cancers. JAMA Oncol. 2018 05 01; 4(5):686-693.
View in:
PubMed
Cancer drug shortages: Awareness and perspectives from a representative sample of the US population. Cancer. 2018 05 15; 124(10):2205-2211.
View in:
PubMed
Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival. Cancer Epidemiol Biomarkers Prev. 2018 03; 27(3):345-347.
View in:
PubMed
What Does a Cancer Diagnosis Mean? Public Expectations in a Shifting Therapeutic Environment. J Oncol Pract. 2018 03; 14(3):139-140.
View in:
PubMed
Management of older adults with myelodysplastic syndromes (MDS). J Geriatr Oncol. 2018 07; 9(4):302-307.
View in:
PubMed
Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes. Cancer. 2018 03 15; 124(6):1251-1259.
View in:
PubMed
Frailty and the management of hematologic malignancies. Blood. 2018 02 01; 131(5):515-524.
View in:
PubMed
Risk and timing of cardiovascular death among patients with myelodysplastic syndromes. Blood Adv. 2017 Oct 24; 1(23):2032-2040.
View in:
PubMed
Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study. PLoS One. 2017; 12(9):e0184747.
View in:
PubMed
Aptitude; Mother's Day; Winter Beach. J Clin Oncol. 2017 Aug 20; 35(24):2848.
View in:
PubMed
Why are patients with blood cancers more likely to die without hospice? Cancer. 2017 Sep 01; 123(17):3377-3384.
View in:
PubMed
Self-reported sleep disturbance and survival in myelodysplastic syndromes. Br J Haematol. 2017 05; 177(4):562-566.
View in:
PubMed
Low-molecular weight heparin versus vitamin K antagonists for the treatment of cancer-associated thrombosis: A cost-effectiveness analysis. Thromb Res. 2017 Feb; 150:53-58.
View in:
PubMed
Assessing Quality of Care for the Myelodysplastic Syndromes. Curr Hematol Malig Rep. 2016 12; 11(6):402-407.
View in:
PubMed
Direct-to-Consumer Drug Advertising in Oncology Is Not Beneficial to Patients or Public Health. JAMA Oncol. 2016 Nov 01; 2(11):1397-1398.
View in:
PubMed
Small Step for Geriatric Oncology That Could Have Been a Giant Leap. J Clin Oncol. 2016 11 20; 34(33):4048-4049.
View in:
PubMed
High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex. J Natl Compr Canc Netw. 2016 10; 14(10):1274-1281.
View in:
PubMed
Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes. Br J Haematol. 2016 Dec; 175(5):829-840.
View in:
PubMed
Modest improvement in survival of patients with refractory anemia with excess blasts in the hypomethylating agents era in the United States. Leuk Lymphoma. 2017 04; 58(4):982-985.
View in:
PubMed
Relationship between physician and patient assessment of performance status and survival in a large cohort of patients with haematologic malignancies. Br J Cancer. 2016 09 27; 115(7):858-61.
View in:
PubMed
Barriers to Quality End-of-Life Care for Patients With Blood Cancers. J Clin Oncol. 2016 09 10; 34(26):3126-32.
View in:
PubMed
Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysis. Lancet Haematol. 2016 Jun; 3(6):e276-83.
View in:
PubMed
Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016 08; 22(8):1504-1510.
View in:
PubMed
Novel Data Sharing Between a Comprehensive Cancer Center and a Private Payer to Better Understand Care at the End of Life. J Pain Symptom Manage. 2016 08; 52(2):161-9.
View in:
PubMed
Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS). Haematologica. 2016 06; 101(6):781-8.
View in:
PubMed
Influence of patient and provider characteristics on quality of care for the myelodysplastic syndromes. Br J Haematol. 2016 06; 173(5):713-21.
View in:
PubMed
Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database. Cancer. 2016 Apr 15; 122(8):1209-15.
View in:
PubMed
Timeliness of End-of-Life Discussions for Blood Cancers: A National Survey of Hematologic Oncologists. JAMA Intern Med. 2016 Feb; 176(2):263-5.
View in:
PubMed
Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic Syndromes. Am Soc Clin Oncol Educ Book. 2016; 35:e337-44.
View in:
PubMed
Potentially avoidable hospitalizations in older patients with acute myeloid leukemia (AML). J Clin Oncol. 2015 Oct 10; 33(29_suppl):206.
View in:
PubMed
Impact of sleep disturbance in myelodysplastic syndromes (MDS). J Clin Oncol. 2015 Oct 10; 33(29_suppl):99.
View in:
PubMed
Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability. J Natl Cancer Inst. 2016 Jan; 108(1).
View in:
PubMed
Accessibility and Quality of Online Cancer-Related Clinical Trial Information for Naïve Searchers. Cancer Epidemiol Biomarkers Prev. 2015 Oct; 24(10):1629-31.
View in:
PubMed
Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adults. J Geriatr Oncol. 2015 Jul; 6(4):288-98.
View in:
PubMed
Health care utilization and end-of-life care for older patients with acute myeloid leukemia. Cancer. 2015 Aug 15; 121(16):2840-8.
View in:
PubMed
Does surveillance imaging after treatment for diffuse large B-cell lymphoma really work? J Clin Oncol. 2015 May 01; 33(13):1427-9.
View in:
PubMed
Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project. Cancer. 2015 Apr 01; 121(7):1032-9.
View in:
PubMed
Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families. Biol Blood Marrow Transplant. 2015 Feb; 21(2):312-8.
View in:
PubMed
Novel data sharing between a comprehensive cancer center and a private payer to better understand care at the end of life. J Clin Oncol. 2014 Oct 20; 32(30_suppl):1.
View in:
PubMed
Quality of end-of-life care: Are blood cancers different? J Clin Oncol. 2014 Oct 20; 32(30_suppl):195.
View in:
PubMed
Measuring quality of life in chronic hematologic malignancy: The QUALMS-1. J Clin Oncol. 2014 Oct 20; 32(30_suppl):263.
View in:
PubMed
End-of-life care for blood cancers: a series of focus groups with hematologic oncologists. J Oncol Pract. 2014 Nov; 10(6):e396-403.
View in:
PubMed
Derivation and validation of the SEER-Medicare myelodysplastic syndromes risk score (SMMRS). Leuk Res. 2014 Dec; 38(12):1420-4.
View in:
PubMed
Limited stage diffuse large B-cell lymphoma: comparative effectiveness of treatment strategies in a large cohort of elderly patients. Leuk Lymphoma. 2015 Mar; 56(3):716-24.
View in:
PubMed
Financial hardship and the intensity of medical care received near death. Psychooncology. 2015 May; 24(5):572-8.
View in:
PubMed
Public advertising by cancer centers: are more data needed? Ann Intern Med. 2014 Jun 17; 160(12):870-1.
View in:
PubMed
Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network. Cancer. 2014 Jul 01; 120(13):1993-9.
View in:
PubMed
Reply to quality control of bone marrow aspirates: additional steps toward a safer and more efficient procedure. Cancer. 2014 May 01; 120(9):1442.
View in:
PubMed
Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life. Blood. 2014 Jan 16; 123(3):451-2.
View in:
PubMed
Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol. 2014 Feb 01; 32(4):306-11.
View in:
PubMed
A novel community-based delivery model to combat cancer disparities. Healthc (Amst). 2013 Dec; 1(3-4):123-9.
View in:
PubMed
Using FastTrack to Implement an Academic Medical Center and Community Health Center Collaborative for Cancer Care Delivery. Healthc (Amst). 2013 Dec; 1(3-4):130-135.
View in:
PubMed
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood. 2014 Feb 06; 123(6):837-42.
View in:
PubMed
Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database. Br J Haematol. 2013 Nov; 163(4):487-95.
View in:
PubMed
International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24. Qual Life Res. 2014 Apr; 23(3):825-36.
View in:
PubMed
Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project. Cancer. 2013 Oct 15; 119(20):3662-71.
View in:
PubMed
Improving the quality of bone marrow assessment: Impact of operator techniques and use of a specimen preparation checklist. Cancer. 2013 Oct 01; 119(19):3472-8.
View in:
PubMed
Geriatric assessment in older patients with acute myeloid leukemia: a retrospective study of associated treatment and outcomes. Leuk Res. 2013 Sep; 37(9):998-1003.
View in:
PubMed
Multiple myeloma treatment transformed: a population-based study of changes in initial management approaches in the United States. J Clin Oncol. 2013 Jun 01; 31(16):1984-9.
View in:
PubMed
Optimal positioning of hematopoietic stem cell transplantation for older patients with myelodysplastic syndromes. Curr Opin Hematol. 2013 Mar; 20(2):150-6.
View in:
PubMed
Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1-2 follicular lymphoma and its impact on initial treatment strategy in the National Comprehensive Cancer Network Non-Hodgkin Lymphoma Outcomes database. Leuk Lymphoma. 2013 Oct; 54(10):2155-62.
View in:
PubMed
Impact of oncology-related direct-to-consumer advertising: association with appropriate and inappropriate prescriptions. Cancer. 2013 Mar 01; 119(5):1065-72.
View in:
PubMed
Comparative rates of adverse events with different formulations of intravenous iron. Am J Hematol. 2012 Nov; 87(11):E123-4.
View in:
PubMed
Referrals for suspected hematologic malignancy: a survey of primary care physicians. Am J Hematol. 2012 Jun; 87(6):634-6.
View in:
PubMed
Update on Direct-to-Consumer Marketing in Oncology. J Oncol Pract. 2012 Mar; 8(2):124-7.
View in:
PubMed
High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database. Leuk Lymphoma. 2012 Jun; 53(6):1113-6.
View in:
PubMed
Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database. Blood. 2012 Mar 01; 119(9):2093-9.
View in:
PubMed
Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: findings from a large national database. Cancer. 2012 Jun 01; 118(11):2944-51.
View in:
PubMed
Sunlight exposure, vitamin D, and risk of non-Hodgkin lymphoma in the Nurses' Health Study. Cancer Causes Control. 2011 Dec; 22(12):1731-41.
View in:
PubMed
The real world: CLL. Blood. 2011 Mar 31; 117(13):3481-2.
View in:
PubMed
Cancer disparities in the context of Medicaid insurance: a comparison of survival for acute myeloid leukemia and Hodgkin's lymphoma by Medicaid enrollment. Oncologist. 2011; 16(8):1082-91.
View in:
PubMed
Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic leukemia. Cancer. 2011 Apr 01; 117(7):1470-7.
View in:
PubMed
Outcomes for lymphoid malignancies in the Nurses' Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program. Hematol Oncol. 2010 Sep; 28(3):133-6.
View in:
PubMed
Classification of the myelodysplastic syndrome in a national registry of recently diagnosed patients. Leuk Res. 2010 Jul; 34(7):939-41.
View in:
PubMed
Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active cancer treatment. J Clin Oncol. 2009 Sep 01; 27(25):4182-7.
View in:
PubMed
Diagnostic delay and complications for older adults with multiple myeloma. Leuk Lymphoma. 2009 Mar; 50(3):392-400.
View in:
PubMed
Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network. J Clin Oncol. 2008 Nov 01; 26(31):5107-12.
View in:
PubMed
Direct-to-consumer advertising for bleeding disorders: a content analysis and expert evaluation of advertising claims. J Thromb Haemost. 2008 Oct; 6(10):1680-4.
View in:
PubMed
Delays in referral and diagnosis for chronic hematologic malignancies: a literature review. Leuk Lymphoma. 2008 Jul; 49(7):1352-9.
View in:
PubMed
Clinical JAK2V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locations. Am J Hematol. 2008 Jun; 83(6):519-20.
View in:
PubMed
Chemotherapy as language: sound symbolism in cancer medication names. Soc Sci Med. 2008 Apr; 66(8):1863-9.
View in:
PubMed
Direct-to-consumer advertising in oncology: a content analysis of print media. J Clin Oncol. 2007 Apr 01; 25(10):1267-71.
View in:
PubMed
Direct-to-consumer advertising in oncology. Oncologist. 2006 Feb; 11(2):217-26.
View in:
PubMed
Effects of biochemically confirmed smoking cessation on white blood cell count. Mayo Clin Proc. 2005 Aug; 80(8):1022-8.
View in:
PubMed
Reporting enrollment in clinical trials. Ann Intern Med. 2002 Dec 17; 137(12):1007-8; author reply 1007-8.
View in:
PubMed